Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Activin A Limits VEGF-Induced Permeability via VE-PTP

International Journal of Molecular Sciences(2023)10.3390/ijms24108698Source: DataRank Database

Activin A Limits VEGF-Induced Permeability via VE-PTP is a research paper published in International Journal of Molecular Sciences (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 0.47)OA: goldTopics (48)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (3)

Lina Lietuvninkas,Andrius Kazlauskas ORCID,Basma Baccouche

Live enrichment

PubMed:37240047 PMC:PMC10218593 OpenAlex:https://openalex.org/W4376614809

Illinois Society to Prevent Blindness

Grant: EY031350

Illinois Society to Prevent Blindness

Grant: P30 EY001792

NEI NIH HHS

Grant: R01 EY031350

National Institutes of Health

Grant: 2P30EY001792-36A1

Instrument Shop Core

National Institutes of Health

Grant: 5R01EY031350-03

Anti-VEGF-mediated barrier closure

Research to Prevent Blindness Foundation

Illinois Society to Prevent Blindness

FWCI

0.47

Citation Percentile

0.6%

Citation Trend

2023

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1422-0067/24/10/8698/pdf?version=1684132037

publisherhttps://www.mdpi.com/1422-0067/24/10/8698/pdf?version=1684132037

publisherhttps://www.mdpi.com/1422-0067/24/10/8698/pdf

journalhttps://doi.org/10.3390/ijms24108698

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37240047

Fields of Study

TGF-β signaling in diseasesAngiogenesis and VEGF in CancerConnective Tissue Growth Factor Research0301 basic medicine03 medical and health sciences

MeSH Terms

Endothelium, VascularHumansTransforming Growth Factor betaProtein Tyrosine PhosphatasesActivinsVascular Endothelial Growth Factor AEndothelial CellsTransforming Growth Factor beta1Growth Differentiation Factor 2

Keywords

Activin type 2 receptorsVascular endothelial growth factorCell biologyEndocrinologyInternal medicineTransforming growth factorChemistryVascular permeabilityDephosphorylationVascular endothelial growth factor BProtein tyrosine phosphataseVascular endothelial growth factor ABiologyTGF beta signaling pathwayCancer researchPhosphorylationPhosphataseMedicineVEGF receptorsFollistatinVEGFPermeabilityActivincrosstalkVe-ptpEndothelial CellsArticleActivinsTransforming Growth Factor beta1Transforming Growth Factor betaGrowth Differentiation Factor 2HumansEndothelium, VascularProtein Tyrosine Phosphatases

Sustainable Development Goals

SDG 0: Good health and well-being